About this document
1 s2.0 S0168365920300778 Main PDF by tomp85224 is a document available to read on EtoBox.
This review article discusses the advancements and challenges in drug delivery systems (DDS) formulated as eye drops, which are commonly used for ocular disease treatment but suffer from low bioavailability. It highlights recent developments in DDS, including in situ gelling systems and nanoparticles, that have shown improved performance in vivo compared to standard formulations. The article also addresses the limitations in clinical translation and commercialization of these new DDS technologies.
- Author
- tomp85224
- Language
- EN